Cochrane Abstracts
Galantamine for vascular cognitive impairment
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Galantamine for Vascular Cognitive Impairment." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436584/1/Galantamine_for_vascular_cognitive_impairment.
Galantamine for vascular cognitive impairment. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436584/1/Galantamine_for_vascular_cognitive_impairment. Accessed October 31, 2025.
Galantamine for vascular cognitive impairment. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436584/1/Galantamine_for_vascular_cognitive_impairment
Galantamine for Vascular Cognitive Impairment [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 October 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436584/1/Galantamine_for_vascular_cognitive_impairment.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Galantamine for vascular cognitive impairment
ID - 436584
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436584/1/Galantamine_for_vascular_cognitive_impairment
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
